Offer - Urjas Oil for just ₹ 1 X
Monocef O CV 100/62.5 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Monocef O CV 100/62.5 Tablet (10) have also been explained below.
The correct dosage of Monocef O CV 100/62.5 Tablet (10) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Monocef O CV 100/62.5 Tablet (10) as well, which are listed below. Such side effects of Monocef O CV 100/62.5 Tablet (10) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Monocef O CV 100/62.5 Tablet (10)'s effect during pregnancy is Mild and Moderate while nursing. In addition, Monocef O CV 100/62.5 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Monocef O CV 100/62.5 Tablet (10) related warnings section.
Monocef O CV 100/62.5 Tablet (10) is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. Some other conditions that can be affected by Monocef O CV 100/62.5 Tablet (10) are listed in the contraindications section below.
Drug reaction of Monocef O CV 100/62.5 Tablet (10) with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Monocef O CV 100/62.5 Tablet (10), it is important to know that it is safe while driving, and is habit-forming.
Monocef O CV 100/62.5 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Monocef O CV 100/62.5 Tablet (10) safe for pregnant women?
Monocef O CV rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Monocef O CV 100/62.5 Tablet (10) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Monocef O CV. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Monocef O CV 100/62.5 Tablet (10) on the Kidneys?
There can be some harmful effects on your kidneys after taking Monocef O CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Monocef O CV 100/62.5 Tablet (10) on the Liver?
Monocef O CV may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Monocef O CV 100/62.5 Tablet (10) on the Heart?
Monocef O CV has very mild side effects on the heart.
Monocef O CV 100/62.5 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Monocef O CV 100/62.5 Tablet (10) unless your doctor advises you to do so -
Is this Monocef O CV 100/62.5 Tablet (10) habit forming or addictive?
No, you will not get addicted to Monocef O CV 100/62.5 Tablet (10).
Interaction between Food and Monocef O CV 100/62.5 Tablet (10)
Taking Monocef O CV 100/62.5 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Monocef O CV 100/62.5 Tablet (10)
It is difficult to say anything about the effect of Monocef O CV 100/62.5 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311